|
ZNF697 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.154000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.106480E-02 |
| Normal-vs-Stage2 |
9.786200E-01 |
| Normal-vs-Stage3 |
2.159200E-01 |
| Normal-vs-Stage4 |
2.790000E-02 |
| Stage1-vs-Stage2 |
4.547700E-02 |
| Stage1-vs-Stage3 |
2.050400E-01 |
| Stage1-vs-Stage4 |
6.996400E-01 |
| Stage2-vs-Stage3 |
2.584800E-01 |
| Stage2-vs-Stage4 |
5.678100E-02 |
| Stage3-vs-Stage4 |
2.663000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.304600E-03 |
| Normal-vs-AfricanAmerican |
6.652600E-01 |
| Normal-vs-Asian |
5.248300E-02 |
| Caucasian-vs-AfricanAmerican |
1.663590E-01 |
| Caucasian-vs-Asian |
9.006000E-01 |
| AfricanAmerican-vs-Asian |
2.487200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.976900E-03 |
| Normal-vs-Female |
1.125560E-01 |
| Male-vs-Female |
5.265500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.784600E-03 |
| Normal-vs-Age(41-60Yrs) |
7.316200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.468000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.362570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.113040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.106250E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.897800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.541960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.320800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.061800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.012800E-01 |
| Classical-VS-Follicular |
1.240830E-04 |
| Classical-VS-Other |
8.662800E-01 |
| Classical-VS-Normal |
2.939600E-03 |
| Tall-VS-Follicular |
1.937950E-01 |
| Tall-VS-Other |
6.981400E-01 |
| Tall-VS-Normal |
3.928600E-01 |
| Follicular-VS-Other |
2.762400E-01 |
| Follicular-VS-Normal |
4.820200E-01 |
| Other-VS-Normal |
3.210000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.691780E-01 |
| Normal-vs-N1 |
7.179500E-04 |
| N0-vs-N1 |
8.321800E-03 |
|
|
